These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33750742)

  • 1. New SARS-CoV-2 Variants Challenge Vaccines Protection.
    Soriano V; Fernández-Montero JV
    AIDS Rev; 2021 Feb; 23(1):57-58. PubMed ID: 33750742
    [No Abstract]   [Full Text] [Related]  

  • 2. Audio Interview: Addressing the Omicron Variant of SARS-CoV-2.
    Rubin EJ; Baden LR; Barocas JA; Morrissey S
    N Engl J Med; 2022 Jan; 386(4):e16. PubMed ID: 35081288
    [No Abstract]   [Full Text] [Related]  

  • 3. Stopping pandemics before they start: Lessons learned from SARS-CoV-2.
    Edwards AM; Baric RS; Saphire EO; Ulmer JB
    Science; 2022 Mar; 375(6585):1133-1139. PubMed ID: 35271333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why scientists are racing to develop more COVID antivirals.
    Kozlov M
    Nature; 2022 Jan; 601(7894):496. PubMed ID: 35064230
    [No Abstract]   [Full Text] [Related]  

  • 5. A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.
    Borio LL; Bright RA; Emanuel EJ
    JAMA; 2022 Jan; 327(3):215-216. PubMed ID: 34989782
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular Research on Coronavirus: Pathogenic Mechanisms, Antiviral Drugs, and New Vaccines.
    Zhang M; Lang Y; Li W
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to redesign COVID vaccines so they protect against variants.
    Callaway E; Ledford H
    Nature; 2021 Feb; 590(7844):15-16. PubMed ID: 33514888
    [No Abstract]   [Full Text] [Related]  

  • 8. Pfizer COVID vaccine protects against worrying coronavirus variants.
    Callaway E
    Nature; 2021 May; 593(7859):325-326. PubMed ID: 33963317
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern.
    Yue L; Zhou J; Zhou Y; Yang X; Xie T; Yang M; Zhao H; Zhao Y; Yang T; Li H; Xiang H; Wang J; Lu S; Liu H; Zhao H; Wei X; Zhang Y; Xie Z
    Emerg Microbes Infect; 2021 Dec; 10(1):2125-2127. PubMed ID: 34666622
    [No Abstract]   [Full Text] [Related]  

  • 10. Novavax offers first evidence that COVID vaccines protect people against variants.
    Callaway E; Mallapaty S
    Nature; 2021 Feb; 590(7844):17. PubMed ID: 33510489
    [No Abstract]   [Full Text] [Related]  

  • 11. An EUA for bamlanivimab and etesevimab for COVID-19.
    Med Lett Drugs Ther; 2021 Apr; 63(1621):49-50. PubMed ID: 33830966
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 Variants in Patients with Immunosuppression.
    Corey L; Beyrer C; Cohen MS; Michael NL; Bedford T; Rolland M
    N Engl J Med; 2021 Aug; 385(6):562-566. PubMed ID: 34347959
    [No Abstract]   [Full Text] [Related]  

  • 13. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants.
    Zani A; Caccuri F; Messali S; Bonfanti C; Caruso A
    Emerg Microbes Infect; 2021 Dec; 10(1):1241-1243. PubMed ID: 34092181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reflections on SARS-CoV-2 new strain contagiousness and its prevention with mRNA vaccines.
    García-Vigil JL; García-Alvarez JL
    Gac Med Mex; 2021; 157(3):318. PubMed ID: 34667321
    [No Abstract]   [Full Text] [Related]  

  • 15.
    Brown RE; Tahseen D
    Ann Clin Lab Sci; 2020 Nov; 50(6):837-841. PubMed ID: 33334802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies.
    Xie X; Han JB; Ma G; Feng XL; Li X; Zou QC; Deng ZH; Zeng J
    Zool Res; 2021 Nov; 42(6):789-791. PubMed ID: 34704423
    [No Abstract]   [Full Text] [Related]  

  • 17. A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics.
    Forchette L; Sebastian W; Liu T
    Curr Med Sci; 2021 Dec; 41(6):1037-1051. PubMed ID: 34241776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How 'killer' T cells could boost COVID immunity in face of new variants.
    Ledford H
    Nature; 2021 Feb; 590(7846):374-375. PubMed ID: 33580217
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 infection and disease outcomes in non-human primate models: advances and implications.
    Yuan L; Tang Q; Zhu H; Guan Y; Cheng T; Xia N
    Emerg Microbes Infect; 2021 Dec; 10(1):1881-1889. PubMed ID: 34490832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three, four or more: what's the magic number for booster shots?
    Watson C
    Nature; 2022 Feb; 602(7895):17-18. PubMed ID: 35091715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.